Two Sigma Securities’s Amicus Therapeutics FOLD Stock Holding History

Two Sigma Securities’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$173K	Buy	+11,955	New	+$171K	0.02%	1078
2025 Q4	–	Sell	-10,848	Closed	-$85.5K	–	1655
2025 Q3	$85.5K	Buy	+10,848	New	+$77.2K	0.01%	927
2025 Q2	–	Sell	-10,021	Closed	-$81.8K	–	1691
2025 Q1	$81.8K	Buy	+10,021	New	+$92.7K	0.01%	954
2024 Q4	–	Sell	-13,439	Closed	-$144K	–	2214
2024 Q3	$144K	Buy	+13,439	New	+$146K	﹤0.01%	2219
2023 Q2	–	Sell	-12,729	Closed	-$141K	–	2965
2023 Q1	$141K	Buy	+12,729	New	+$157K	﹤0.01%	2150
2017 Q3	–	Sell	-11,539	Closed	-$116K	–	1009
2017 Q2	$116K	Buy	+11,539	New	+$92.8K	0.02%	638

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Securities's FOLD Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 11,955 shares worth $173K. The stake represents 0.02% of the portfolio and ranks #1078 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in FOLD as recently as Q3 2025.

Two Sigma Securities first reported a position in FOLD in Q2 2017 and has held it in 6 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Two Sigma Securities held 11,955 shares of Amicus Therapeutics worth $173K as of Q1 2026.
Amicus Therapeutics was a new Two Sigma Securities position in Q1 2026.
Amicus Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1078 holding.
Two Sigma Securities first reported a position in Amicus Therapeutics in Q2 2017 and has held it in 6 quarters since.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.